Radiolabeled peptide probe for tumor imaging

Recommendations on the Use of ¹⁸F-FDG PET in Oncology

James Fletcher, Benjamin Djulbegović, Heloisa P. Soares et al. · Journal of Nuclear Medicine · 2008 · 1.1K citations · Full text

Medicine, Oncology, Cancer Screening +14

PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles

Ha‐Young Lee, Zibo Li, Kai Chen et al. · Journal of Nuclear Medicine · 2008 · 546 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients

Dik J. Kwekkeboom, Willem H. Bakker, P.P.M. Kooij et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 471 citations

Medicine, Endocrinology, Nuclear Medicine +3

cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

Xiaoqiang Yang, Hao Hong, Jamison Grailer et al. · Biomaterials · 2011 · 438 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16

Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature

Weibo Cai, Kang Chen, Zibo Li et al. · Journal of Nuclear Medicine · 2007 · 428 citations · Full text

Medicine, Oncology, Pharmacokinetics +17